All In the pipeline articles – Page 6

View all stories with this category.

  • x0612CW_PIPELINE_pg021-300
    Opinion

    Peace, love and understanding

    2012-06-01T00:00:00Z

    Chemists and biologists often view the process of drug discovery very differently

  • Opinion

    Passion of the chemist

    2012-04-30T00:00:00Z

    It took Derek Lowe a while to find his motivation

  • Opinion

    Feeling the burn

    2012-04-01T00:00:00Z

    How long is ‘too long’ in the drug discovery game?

  • Opinion

    Column: In the pipeline

    2012-02-23T13:01:15Z

    Drug discovery requires experimentation, says Derek Lowe. But chemists can be reluctant to stray from the elements they know and love

  • Opinion

    Column: In the pipeline

    2012-01-27T10:21:39Z

    Derek Lowe wonders what the lab lingua franca might be in the years to come

  • Opinion

    Column: In the pipeline

    2011-12-22T10:14:33Z

    Derek Lowe discusses how companies are increasingly trying to do more with the compounds they already know a lot about

  • Opinion

    Column: In the pipeline

    2011-11-28T15:10:54Z

    Derek Lowes considers the perfect lab environment

  • Opinion

    Column: In the pipeline

    2011-10-26T15:15:37Z

    Derek Lowe discusses the compounds you can buy but won't see anywhere in the literature

  • Opinion

    Column: In the pipeline

    2011-09-29T13:41:59Z

    You have to make space for good sense when thinking about safety, argues Derek Lowe

  • Opinion

    Column: In the pipeline

    2011-08-26T14:23:02Z

    Derek Lowe considers an increasingly popular business strategy in the drug industry, the much discussed 'pay for delay' deal

  • Opinion

    Column: In the pipeline

    2011-07-28T15:17:56Z

    Derek Lowe highlights the less visible pitfalls on the road to a new drug

  • Opinion

    Column: In the pipeline

    2011-06-30T09:50:26Z

    The financial markets can be a rollercoaster ride, writes Derek Lowe, so should chemists working in industry worry about the company share price?

  • Opinion

    Column: In the pipeline

    2011-05-31T11:23:38Z

    To the unfamiliar, chemists might all look the same. But some common categories are easy to identify, explains Derek Lowe

  • Opinion

    Column: In the pipeline

    2011-04-28T09:15:24Z

    The map of scientific disciplines is growing ever more complex. Derek Lowe surveys the country

  • Opinion

    Column: In the pipeline

    2011-03-30T08:37:00Z

    'Natural products are back!' is a headline Derek Lowe has seen several times before

  • Opinion

    Column: In the pipeline

    2011-02-24T10:48:16Z

    Drug discovery is an inherently risky business. Derek Lowe tries to balance some of the risk equations

  • Opinion

    Column: In the pipeline

    2011-01-31T09:55:05Z

    Enzymes have been giving chemists inferiority complexes since day one, says Derek Lowe. But there's no denying their potential

  • Opinion

    Column: In the pipeline

    2011-01-05T09:59:00Z

    Some medicinal chemists can't get enough fluorines in their molecules. Derek Lowe explains the love-hate relationship

  • Opinion

    Column: In the pipeline

    2010-11-29T13:25:21Z

    Who's that asleep at the back? Don't be too quick to blame yourself when tedious talks and soporific seminars fail to inspire, says Derek Lowe

  • Opinion

    Column: In the pipeline

    2010-10-28T10:14:50Z

    Should companies focus on big markets and the blockbuster dream? The more modern approaches are not without risks, says Derek Lowe